Cancer BiologybioRxiv
Systematic analysis uncovers SYK dependency in NF1LoF melanoma cells
C. Abecunas, C. Whitehead, E. Ziemke…·M. Fallahi-Sichani
This study identifies SYK as a therapeutic target in NF1LoF melanoma cells, showing that MTX-216, a compound inhibiting both PI3K and SYK, effectively blocks tumor growth.
DOI 10.1158/0008-5472.can-22-0883